The Geschwind Laboratory is dedicated to improving the understanding and treatment of neurodevelopmental and neurodegenerative conditions, focusing on autism spectrum disorders (ASD), dementia (frontotemporal dementia and progressive supranuclear palsy), and repair of the damaged nervous system. To accomplish this, we leverage the fields of genetics and genomics, coupled with basic neurobiology, to obtain a systems level understanding of disease. This process, which includes many stages (see below), begins with finding genes that increase risk for disease.
We gratefully acknowledge funding support from the NIH (NIMH, NIA, NINDS), the Adelson Medical Research Foundation (AMRF), the Tau Consortium, the Simons Foundation for Autism Research Inititative (SFARI), the Paul G. Allen Frontiers Group, the Friedrich's Ataxia Research Alliance (FARA), as well as the Gordon and Virginia MacDonald Distinguished Professorship.